G
Ganymed Robotics
Ganymed retools orthopaedics with robotics. Their product is a compact, ergonomic, and cost-effective joint-replacement device. The robot's intelligence and perception are driven by computer vision
About Ganymed Robotics
Developer of a therapeutic device designed to enhance surgical precision in knee replacement surgery. The company's device uses robotic technology to improve patient outcomes, surgeon experience, and overall efficiency of care delivery for its target indications, enabling orthopedic surgeons to reduce their operating time.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2018
- Headquarters
- Paris, France
- Employees
- 30
- Open positions
- 2
- Dealroom signal
- 64.7/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Surgery, Core AI, Orthopedic, EIC, Medical Robots
- Technology
- Artificial Intelligence, Hardware, Deep Tech, Computer Vision, Recognition Technology
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| DEBT✓Debt | Jan 2023 | $1.1M | — | Bpifrance | ↗ |
| SERIES B✓Equity / VC | Jan 2023 | $17M | $116M | CapHorn · EIC Fund | ↗ |
Growth signals
Latest recorded traffic for Ganymed Robotics is 1.9K monthly website visits, up 900% over the last three months. Ganymed Robotics's team declined 11.8% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
EIT Health
European Innovation Council
Series A7 investors entered at this stage
EIC Fund
Cathay Capital
Crédit Mutuel Innovation
Kurma Partners
BNP Paribas Développement
Crédit Mutuel Equity
CapHorn
Series B and later1 investor entered at this stage
Other known investors4 additional known investors
Agoranov
Alexandre Heraud
Cathay Health
Paris Biotech Santé
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Ganymed Robotics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Ganymed Robotics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








